Testing tricky blood cancer diagnoses with advanced DNA sequencing
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study uses advanced DNA sequencing to figure out unclear or unusual blood (hematologic) conditions when standard tests are not enough. It may help your care team reach a more accurate diagnosis by better understanding what’s driving your illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re at least 18 years old
- Your diagnosis is still unclear after usual clinic tests (or your course is unusual)
- Your situation is unusual for your cancer type, including not responding or coming back
- Your blood or bone marrow sample must have at least 20% tumor (cancer) cells
- You can consent to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a new, advanced DNA sequencing method (long-read sequencing) to try to clarify unclear or incomplete genetic test results. If you or a family member have had genetic testing that left unanswered questions, this trial may help find more definite answers.
This study collects and stores blood and bone marrow samples from young people with certain blood cancers so doctors can do genetic (“genomic”) testing now and in the future. It may help improve understanding of the disease and support better matching of care for patients.
This trial uses advanced long-read sequencing technology to find genetic causes of diseases that standard tests may have missed. It may help people with undiagnosed conditions get a precise molecular diagnosis.
This trial compares treatment based on a detailed analysis of your tumor's genes (genome and transcriptome) with standard care. It aims to find better treatment options for people with advanced rare cancers that have not responded to previous therapy.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This study looks at whether a simple blood test (called liquid biopsy) can help monitor how well your cancer treatment is working. By checking for tumor DNA in your blood before and during treatment, researchers hope to see if the treatment is effective and if the cancer is responding, which could help guide your care.
Hear when a new Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.